Product Images Valproic Acid

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Valproic Acid NDC 70518-0730 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Valproic Acid 250mg 70518 0730 00

Valproic Acid 250mg 70518 0730 00

Valproic Acid is a medication available in the form of 250mg capsules contained in a pack of 30. It is a prescription drug and the NDC number of the medicine is 70518-0730-00 5. The medicine is manufactured by Upsher-Smith Labs, Inc., Minneapolis, MN 55447, and packaged by RemedyRepack Inc., Indiana, PA 15701. The drug must be stored at a temperature controlled environment in between 20-25°C (58-77°F) with permissible excursions to 15-30°C (59-86°F) as per USP. The package insert contains direction for use, and the medicine must be kept out of reach of children.*

Valproic Acid 250mg 70518 0730 01

Valproic Acid 250mg 70518 0730 01

Valproic acid is a capsule medication produced by Upsher-Smith Labs, Inc. Each capsule contains 250mg and the bottle includes 100 capsules. The medication is only available with a prescription and should be stored between 20-25°C (58-77°F) with excursions allowed up to 15-30°C (59-86°F). The lot number and expiration date are required for tracking purposes. To take Valproic Acid, refer to the directions on the package insert. This product has been repackaged by RemedyRepack Inc. in Indiana, PA.*

Valproic Acid 250mg 70518 0730 02

Valproic Acid 250mg 70518 0730 02

Valproic Acid 250mg capsule is a prescription medication used to treat seizures, bipolar disorder or mania. It is manufactured by Upsher-Smith Labs, Inc. and distributed by RemedyRepack Inc. The medication should be kept out of reach of children and stored at a temperature of 20-25°C (58-77°F). Patients should refer to the package insert for usage instructions.*

Chemical Structure - valproic 01

Chemical Structure - valproic 01

Figure 1 - valproic 02

Figure 1 - valproic 02

This document is showing the percentage reduction in CPS rate for patients treated with Divalproex sodium compared to placebo. The results are presented in a table format where the percentage of patients with improvement, no change, and worsening are shown for both treatments. There is no additional information available in the given text.*

Figure 2 - valproic 03

Figure 2 - valproic 03

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.